SECOND AMENDMENT TO PHARMACEUTICAL MANUFACTURER SERVICES AGREEMENT

SECOND AMENDMENT
TO

PHARMACEUTICAL MANUFACTURER SERVICES AGREEMENT

This Second Amendment to Pharmaceutical Manufacturer Services Agreement (this “Amendment”) is made and entered into as of October 6, 2014 by and between CORCEPT THERAPEUTICS INCORPORATED, a Delaware corporation (“Client” or “Corcept”), and DOHMEN LIFE SCIENCE SERVICES, LLC (AS SUCCESSOR-IN-INTEREST TO CENTRIC HEALTH RESOURCES, INC.), a Wisconsin limited liability company (“DLSS”).

WHEREAS, Client and DLSS entered into that certain Pharmaceutical Manufacturer Services Agreement dated effective as of May 21, 2013, as amended (the “Agreement”); and

WHEREAS, the parties hereto now desire to amend and supplement the Agreement as hereinafter provided.

NOW, THEREFORE, in consideration of the mutual covenants, terms and conditions set forth herein, the parties agree as follows:

The Fee set forth in Description #2 and #4 above will each be automatically adjusted by DLSS, effective as of January 1 of each calendar year, commencing with January 1, 2015, by the annual average percentage increase in the Consumer Price Index (“CPI-U”),

U.S. City Average, All Items, published monthly by the Bureau of Labor Statistics of the U.S. Department of Labor (or if the Index is no longer published or issued, any successor index or other reliable governmental or nonpartisan publication evaluating the information previously used in the determination of the index that is mutually selected by the parties) for the most recently completed 12 month period for which the CPI-U percentage is available at the time the adjustment calculation is performed by DLSS.

[Signature Page(s) to Follow]

IN WITNESS WHEREOF, the parties have caused this Amendment to be executed by duly authorized representatives as of the date first set forth above.

DOHMEN LIFE SCIENCE SERVICES, LLC

By: /s/ Cynthia Laconte _____________________________________

Name: Cynthia Laconte ___________________________________

Title: CEO ____________________________________

CORCEPT THERAPEUTICS INCORPORATED

By: /s/ Steven Lo _____________________________________

Name: Steven Lo ___________________________________

Title: SVP, Chief Commercial Officer ____________________________________

SCHEDULE  A

DLSS and Corcept will create a customized operational blue print outlining the specifications to guide the implementation for the Korlym 3PL service program including order to cash management, order fulfillment, logistics and distribution support, invoicing and cash collections, inventory management, and reporting services (the “3PL Program”).

For all purposes of the Agreement, the term “Program” shall include the 3PL Program.

    The services to be included in the 3PL Program shall be as follows:

SCHEDULE  B

PRICING SCHEDULE

The Fee set forth in Description #2 and #3 above will each be automatically adjusted by DLSS, effective as of January 1 of each calendar year, commencing with January 1, 2015, by the annual average percentage increase in the Consumer Price Index (“CPI-U”), U.S. City Average, All Items, published monthly by the Bureau of Labor Statistics of the U.S. Department of Labor (or if the Index is no longer published or issued, any successor index or other reliable governmental or nonpartisan publication evaluating the information previously used in the determination of the index that is mutually selected by

the parties) for the most recently completed 12 month period for which the CPI-U percentage is available at the time the adjustment calculation is performed by DLSS.

Payment Terms

Invoice for services issued on the first of each month for the prior month, due net 30 from receipt date of invoice.  Service charges will apply for each day past the due date at a rate of 1.5% per month.